Effect of a change in the sleep/wake cycle on the diurnal variation of fibrinolytic parameters

Journal of Thrombosis and Thrombolysis

Volumn 5, Issue 2, 1998, Pages 165-168

  Irokawa, Masahiko ^a   Nishinaga, Masanori ^a   Funayama, Hiroshi ^a   Ikeda, Uichi ^a   Shimada, Kazuyuki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Circadian rhythm; Cortisol; Plasminogen activator inhibitor; Tissue plasminogen activator

Indexed keywords

HYDROCORTISONE; PLASMINOGEN ACTIVATOR INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; FIBRINOLYSIS; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SLEEP WAKING CYCLE;

EID: 0031884772     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008838330924     Document Type: Article

References (15)

1. Angleton P, Chandler WL, Schmer G. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1). Circulation 1989;79:101-106.
2. Klufts C, Jie AFH, Rijken DC, Verheijen JH. Daytime fluctuations in blood of tissue-type plasminogen activator (tPA) and its fast-acting inhibitor PAI-1. Thromb Haemost 1988;59:329-332.
3. Huber K, Rose D, Resch I, Schuster E, Glogar DH, Kaindl F, Binder BR. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels of patients with unstable coronary artery disease and acute myocardial infarction. Thromb Haemost 1988;60:372-376.
4. Hamsten A, de Faire U, Walldius G, et al. Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction. Lancet 1987;2:3-9.
5. Muller JE, Ludmer PL, Willich SN, Tofler GH, Aylmer G, Klangos I, Stone PH. Circadian variation in the frequency of sudden cardiac death. Circulation 1987;75:131-138.
6. Rosing DR, Brakman P, Redwood DR, Goldstein RE, Beiser GD, Astrup T, Epstein SE. Blood fibrinolytic activity in man, diurnal variation and the response to varying intensities of exercise. Circ Res 1970;27:171-184.
7. Chau NP, Mallion JM, Gaudemaris R, Ruche E, Siehe JP, Pelen O, Mathern G. Twenty-four-hour ambulatory blood pressure in shift workers. Circulation 1989;80:341-347.
8. Kimura S, Nishinaga M, Ozawa T, Shimada K. Thrombin generation as an acute effect of cigarette smoking. Am Heart J 1994; 128:7-11.
9. Yamamoto K, Ikeda U, Scino Y, et al. Coagulation activity is increased in left atrium of patients with mitral stenosis. J Am Coll Cardiol 1995;25:107-112.
10. Fearnley GR, Balmforth G, Fearnley E. Evidence of a diurnal fibrinolytic rhythm with a simple method of measuring fibrinolysis. Clin Sci 1957; 16:645-650.
11. Cepelak V, Barcal R, Cepelalova H, Mayer O. Circadian rhythm of fibrinolysis. In: Davidson JF, Rowan RM, Samama MM, Desnoyers PC, eds. Progress in Chemical Fibrinolysis and Thrombosis, III. New York: Raven Press, 1978:571-578.
12. Fujiwara S, Shinkai S, Kurokawa Y, Watanabe T. The acute effects of experimental short-term evening and night shifts on human circadian rhythm: The oral temperature, heart rate, serum cortisol and urinary catecholamines levels. Int Arch Occup Environ Health 1992;63:409-418.
13. Touitou Y, Motohashi Y, Reinberg A, Touitou C, Bourdeleau P, Bogdan A, Auzeby A. Effect of shift work on the nighttime secretory patterns of melatonin, prolactin, cortisol and testosterone. Eur J Appl Physiol 1990;60:288-292.
14. Lang WE. Glucocorticoids inhibit plasminogen activator production by endothelial cells. Thromb Haemost 1983;50: 888-892.
15. Chandler WL, Mornin D, Whitten RO, et al. Insulin, cortisol and catecholamines do not regulate circadian variations in fibrinolytic activity. Thromb Res 1990;58:1-12.